节点文献

血清TGF-β1、VEGF-C在非小细胞肺癌病理类型和临床分期诊断中的应用

Application of Serum TGF-β1 and VEGF-C in the Diagnosis of Pathologic Type and Clinical Staging of Non-small Cell Lung Cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 雷泽洪林志潮李荣岗林秀欣甄文光林忠顺黄胜起

【Author】 LEI Zehong;LIN Zhichao;LI Ronggang;LIN Xiuxin;ZHEN Wenguang;LIN Zhongshun;HUANG Shengqi;Jiangmen Central Hospital;

【通讯作者】 雷泽洪;

【机构】 广东省江门市中心医院

【摘要】 目的:分析血清转化生长因子β1(TGF-β1)、血管内皮生长因子C(VEGF-C)在非小细胞肺癌(NSCLC)病理类型和临床分期诊断中的应用价值。方法:选取本院2018年1月-2019年12月收治的100例NSCLC患者作为试验组,同期门诊体检的100例健康人员作为参照组,均进行血清TGF-β1、VEGF-C检测。对比两组血清TGF-β1、VEGF-C水平,对比不同病理类型(鳞癌、腺癌)、临床分期(Ⅰ~Ⅳ期)的血清TGF-β1、VEGF-C水平,分析血清TGF-β1、VEGF-C水平与病理类型、临床分期的相关性。结果:试验组血清TGF-β1、VEGF-C水平均显著比参照组高(P<0.05)。腺癌患者的血清TGF-β1、VEGF-C水平均明显比鳞癌高(P<0.05)。Ⅳ期患者的血清TGF-β1、VEGF-C水平均比Ⅲ期高,Ⅲ期患者均比Ⅱ期高,Ⅱ期患者均比Ⅰ期高(P<0.05)。血清TGF-β1、VEGF-C水平与病理类型、临床分期均呈正相关(P<0.05)。结论:血清TGF-β1、VEGF-C水平与NSCLC患者病情呈正相关,加强血清TGF-β1、VEGF-C检测,对于NSCLC患者病情诊断意义重大。

【Abstract】 Objective:To analyze the clinical value of serum transforming growth factor β1 (TGF-β1) and vascular endothelial growth factor C (VEGF-C) in the diagnosis of pathologic type and clinical staging non-small cell lung cancer (NSCLC).Method:A total of 100 NSCLC patients admitted to our hospital from January 2018 to December 2019 were selected as the experimental group,and a total of 100 healthy people who underwent outpatient physical examination during the same period were selected as the reference group,serum TGF-β1 and VEGF-C were detected in all patients.The levels of serum TGF-β1 and VEGF-C in the two groups were compared,and the levels of serum TGF-β1 and VEGF-C in different pathological types (squamous cell carcinoma,adenocarcinoma) and clinical stages (stage Ⅰ-Ⅳ) were compared.The correlation of serum TGF-β1 and VEGF-C levels with pathological types and clinical stages were analyzed.Result:Serum TGF-β1 and VEGF-C levels in experimental group were significantly higher than those in the control group (P<0.05).Serum TGF-β1 and VEGF-C levels in adenocarcinoma patients were significantly higher than those in squamous cell carcinoma (P<0.05).The serum levels of TGF-β1 and VEGF-C in Ⅳ stage patients were higher than those in the Ⅲ stage,those in the Ⅲ stage were higher than those in the Ⅱ stage,and those in the Ⅱ stage were higher than those in the Ⅰ stage (P<0.05).Serum TGF-β1 and VEGF-C levels were positively correlated with pathological types and clinical stages (P<0.05).Conclusion:Serum TGF-β1 and VEGF-C levels are positively correlated with the conditions of patients with NSCLC.Strengthening the detection of serum TGF-β1 and VEGF-C is of great significance for the diagnosis of the conditions of patients with NSCLC.

【基金】 2019年江门市医疗卫生领域科技计划项目(2019A081)
  • 【文献出处】 中国医学创新 ,Medical Innovation of China , 编辑部邮箱 ,2021年16期
  • 【分类号】R734.2
  • 【下载频次】82
节点文献中: 

本文链接的文献网络图示:

本文的引文网络